Keputusan Menteri Kesehatan Nomor HK.01.07/MENKES/1276/2023 tentang Nilai Klaim Harga Obat Program Rujuk Balik, Obat Penyakit Kronis, Obat Kemoterapi, dan Obat Alteplase | Direktorat Jenderal Kefarmasian dan Alat Kesehatan

By Secretariat of the Directorate General | | 17 April 2023, 15:11 WIB | Read 210 times

Type/Form of Regulation	Ministerial Decree
Number	HK.01.07/MENKES/1276/2023
Year	2023
Regarding	Value of Price Claims for Reverse Referral Program Drugs, Chronic Disease Drugs, Chemotherapy Drugs, and Alteplase Drugs
Date of Establishment	31 March 2023
Regulatory Official	BUDI G. SADIKIN
Year of Enactment	2023
Number of Enactment
Additional Number
Date of Enactment	31 March 2023
Enactment Officer	Indah Febrianti, S.H., M.H.
Status	Repealed
Regulatory Relationship	Repeals Decree of the Minister of Health Number HK.01.07/MENKES/1984/2022 on the Value of Drug Price Claims for the Reverse Referral Program, Chronic Disease Drugs at Advanced Referral Health Facilities, and Chemotherapy Drugs. Repealed by Decree of the Minister of Health Number HK.01.07/MENKES/1905/2023 on the Value of Drug Price Claims for the Referral Program, Chronic Disease Drugs at Advanced Referral Health Facilities, Chemotherapy Drugs, and Alteplase Drugs.

Preview

Download

Decree of the Minister of Health Number HK.01.07/MENKES/1276/2023 on the Value of Price Claims for Reverse Referral Program Drugs, Chronic Disease Drugs, Chemotherapy Drugs, and Alteplase Drugs